M414
Pill imprint M414 has been identified as Fluvoxamine maleate 100 mg.
Fluvoxamine is used in the treatment of obsessive compulsive disorder; anxiety and stress; social anxiety disorder; eating disorder; body dysmorphic disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Risk cannot be ruled out during pregnancy.
Fluvoxamine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Fluvoxamine maleate Images
- Imprint:
-
M414
- Strength:
- 100 mg
- Color:
- Orange
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
hypromelloses
mannitol
polydextrose
polyethylene glycol
povidone
corn starch
sodium stearyl fumarate
titanium dioxide
triacetin
- Drug Class:
- Selective serotonin reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0414
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0993 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Fluvoxamine Maleate resources
- Fluvoxamine (Wolters Kluwer)
- Fluvoxamine Extended-Release Capsules (Wolters Kluwer)
- fluvoxamine (Cerner Multum)
- fluvoxamine (Micromedex) - Includes Dosage Information
- Fluvoxamine Maleate (AHFS DI)
- Fluvoxamine (FDA)
- Fluvoxamine Maleate (Wolters Kluwer)
Search Again
